The long-term effectiveness of five current desensitizing products on cervical dentine sensitivity.
The aim of this study was to compare the long-term effectiveness of five desensitizing products on 25 male and 27 female patients (total 52) aged 21-67 years (mean 36 +/- 7 years) suffering from cervical dentine sensitivity. All subjects were seen by the same examiner (ID) who was blinded to the applied treatment for 3-month clinical study. Patients were asked to record their overall sensitivity by marking a point on a 10 cm Visual Analogue Scale (VAS). Two hundred and seventy-seven sensitive teeth were treated by one of the five desensitizing products, all of which were placed following manufacturers' instructions by the other investigator (AS). A paired (split mouth) study design was used and selection of quadrants was randomized. At the post-treatment and at 10 days and 3 months periods, sensitivity measurements were recorded by the same investigator (ID). Statistical analysis showed that all of the VAS scores at post-treatment evaluation points were significantly decreased compared with baseline data (P < 0.05). There was a significant reduction in mean sensitivity scores in the Protect Liner F and the Health-Dent Desensitizer groups when compared with Fluoline varnish at the 10-day time point (P < 0.05). At 3 months, the Protect Liner F group continued to show a significantly reduced sensitivity level when compared with Health-Dent Desensitizer, Single Bond, Fluoline and Gluma Desensitizer (P < 0.05). The present study demonstrated that although at the end of 3-month evaluation period all desensitizers showed lower VAS sensitivity values compared with baseline, there were differences in the level of reduction of cervical dentine sensitivity.
Duran
I
I
Department of Periodontology, School of Dentistry, Selcuk University, Konya, Turkey.
Sengun
A
A
D000328:Adult; D000368:Aged; D001548:Benzalkonium Compounds / Q000627:therapeutic use; D017438:Bisphenol A-Glycidyl Methacrylate / Q000627:therapeutic use; D003807:Dentin Sensitivity / Q000188:drug therapy* / Q000517:prevention & control; D017220:Dentin-Bonding Agents / Q000627:therapeutic use; D005260:Female; D005976:Glutaral / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use*; D008875:Middle Aged; D010147:Pain Measurement / Q000379:methods; D019279:Resin Cements / Q000627:therapeutic use; D018709:Statistics, Nonparametric; D013997:Time Factors; D019237:Tooth Cervix
D001548:Benzalkonium Compounds; D017220:Dentin-Bonding Agents; C090971:Liner F; D008689:Methacrylates; D019279:Resin Cements; C111486:gluma desensitizer; C111487:health-dent desensitizer; C115612:single bond; D017438:Bisphenol A-Glycidyl Methacrylate; D005976:Glutaral